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Chronic diseases, especially cancer, cardiovascular
disease, and respiratory diseases, are the leading causes
of morbidity and mortality worldwide. In Canada alone,
chronic diseases account for 87% of total disability and
89% of all deaths (1). It is estimated that half of the
Canadian population live currently with a chronic
illness and more than 90% of them have these three
diseases (1). Chronic diseases develop typically over
long periods of time and have multiple risk factors. The
major causes of cardiovascular disease include high
cholesterol, high blood pressure, and obesity (2-6). For
lung cancer and respiratory disease, tobacco smoking
and exposure to toxic chemicals are important risk
factors (7-15). More recently, ambient air pollution has
been implicated in increasing the incidence and
mortality from lung cancer and from cardio-pulmonary
diseases (16-19).
Present-day urban air pollution comprises hundreds of
substances, including sulphur dioxide, ozone, nitrogen
oxide, nitrogen dioxide, carbon monoxide, carbon
dioxide, particulate matter, rubber dust, polycyclic
aromatic hydrocarbons, and many different volatile
organic compounds. Particles are a heterogeneous
mixture of solid and liquid droplets with wide
distributions of size and mass. Coarse particles, greater
than 2.5 μm in median aerodynamic diameter, derive
from a variety of sources including windblown dust and
grinding operations; fine particles are primarily from
the combustion of fossil fuels (20). Common
constituents of particulates include elemental and
organic carbon, sulphates, nitrates, pollen, microbial
contaminants, and metals (20). Fine particles can react
with sulphur dioxide and oxides of nitrogen in the
atmosphere to form strong acids, such as sulphuric acid,
nitric acid, hydrochloric acid, and acid aerosols (20). In
addition, urban air also contains benzene and 1,3-
butadiene that are considered carcinogenic (21). 
The health impact of outdoor air pollution became
apparent during the smog episodes in London, England,
(Figure 1) in the 1950s and in some other places. In
London, the lethal fog, which occurred because a
temperature inversion trapped heavy combustion-
related emissions of particles and SO2 (traffic and coal-
fired heating), resulted in approximately 3,000 more
deaths than normal during the first three weeks of the
smog event (Figure 2) (22). During five days of a smog
episode in Donora, Pennsylvania, a small town of
14,000 residents, 20 people died and over 7,000 were
hospitalized (23). These episodes demonstrated
conclusively that the confluence of adverse weather
conditions and extremely high levels of pollution from
ambient particles and sulphur dioxide can cause
immediate and dramatic increases in mortality (24;25). 
In the subsequent decades, especially in economically
developed countries, changes in fuels (e.g., low sulphur
fuels), improved combustion technology, and
regulations (e.g., the clean air acts in the UK, USA, and
Canada) have led to significant reductions in the levels
of ambient air pollution (Figure 3). Unfortunately, the
situation in some other less developed countries is not
encouraging. For example, Delhi, India, is subjected
frequently to high levels of total suspended particulates,
with an annual mean concentration well exceeding 600
μg/m3 (26). In many other parts of the world, such as
Mexico City and Beijing (Figure 3), similarly high
levels of total suspended particles are observed
frequently (27;28). In contrast, the maximum annual
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Figure 1: The London smog episode of 1952. A photograph during
the day. 59 McGill Journal of Medicine 2009
level of total suspended particles in Windsor, Ontario,
one of the most polluted cities in Canada, is usually
below 120 μg/m3 (29).
THE EVIDENCE
Over the past 25 years, considerable epidemiological
research has been conducted to investigate acute and
chronic effects on health as a result of exposure to
ambient air pollution. The bulk of this work has been
focused on health effects from short-term (i.e., day to
day) fluctuations in ambient levels of pollution.
Associations have been found between exposures
occurring on the day of the event or the preceding days
and daily non-accidental mortality, cardio-respiratory
deaths, hospitalizations, and emergency room visits
(30-50). There is also evidence that certain subgroups of
the population are at higher risk. The conclusion is
clear: short-term elevations of ambient air pollution
cause a variety of acute health events, especially in
certain subgroups of the population, such as the elderly,
children, and those who are impaired physiologically
(e.g., congestive heart failure, diabetes, and
cardiovascular disease) (47;51). In contrast, the effects
of air pollution on chronic diseases have not been
studied as extensively. This is due to the difficulty of
assembling large cohorts, following subjects through a
long enough period of time, and the difficulty in
measuring personal exposures to ambient air pollution. 
We have recently completed a structured review of the
association between long-term exposure to ambient air
pollution and the risks in adults of nonaccidental
mortality and the incidence and mortality from cancer
and cardiovascular and respiratory diseases (52). A total
of 17 cohort studies and 20 case-control studies,
published between 1950 and 2007, of the long-term
effects of air pollution were identified. We abstracted
characteristics of their design and synthesized the
quantitative findings in tabular and graphical form. We
estimated “summary” relative risks for exposure to
certain frequently measured specific pollutants by
combining statistically the estimates from the different
studies. We also assessed whether there were large
variations in the estimates of relative risk between
studies (referred to as “heterogeneity”). 
Our analysis of the published studies showed a 6%
increase in non-accidental mortality for every increase
of 10 μg/m3 of fine particles, independent of age,
gender, and geographic region. This was derived from a
log-linear exposure-response pattern; that is, mortality
increased exponentially with increasing concentrations
of fine particles. 
This result can be translated to an estimate of an
additional risk in nonaccidental mortality of 1.8% for
residents of Windsor, Ontario (annual mean
concentration of fine particles: 13 μg/m3) (53), a 16%
increase in risk for residents of Mexico City (annual
mean of fine particles: 35 μg/m3) (54;55), and a 96.6%
increase in risk for residents of Delhi, India (annual
mean of fine particles: 126 μg/m3) (26) as compared
with those who were exposed to 10 μg/m3 of fine
particles (World Health Organization recommended
long-term guideline value for fine particles) (56).
We also found that long-term exposure to fine
particles was associated log-linearly with an increased
risk of mortality from lung cancer (range: 15%-21% per
a 10 μg/m3 increase) and overall cardiovascular
mortality (range: 12%-14% per a 10 μg/m3 increase)
(Figure 4). In addition, we found living close to
highways or major urban roads appears to be associated
with elevated risks of these three health outcomes. For
the other pollutants and health outcomes, data were not
sufficient to draw any meaningful conclusions. (57-62)
At first glance, the magnitudes of these associations
are smaller than those of some other risk factors, such as
smoking. For example, smoking 1 to 14 cigarettes each
day was associated with a six-fold increase in risk of
dying from lung cancer (63) and a two-fold increase in
fatal coronary heart disease (64;65). It is impossible to
compare these relative risks directly as the metrics of
exposure are different. Because population exposures to
air pollution are virtually ubiquitous, there is a very
large impact on chronic illness due to exposure to
ambient pollution. 
NUMBER OF PERSONS AFFECTED BY AIR
POLLUTION
Using the pooled estimates of relative risks from our
analysis, we estimated that exposure to fine particles at
the current ambient level in Canada would lead to
Figure 2:  The association between total suspended particles, sulphur
dioxide, and nonaccidental deaths during 15 days in the London smog
episode of 1952.  The right hand vertical axis shows the number of
deaths per day and the left hand axis represents concentrations of the
two pollutants, on a relative scale.  60 Air Pollution and Chronic Illnesses Vol. 12  No. 1
approximately 5,000 deaths each year nationwide (66).
Among these deaths, 1,100 deaths would be from lung
cancer and 2,700 deaths would be from cardiovascular
diseases. In fact, it has been reported that for Austria,
France, and Switzerland combined, 40,000 deaths per
year are likely to be attributable to outdoor air pollution
(67). Chronic health effects from exposure to urban air
pollution have thus been estimated to account for
almost 60% of the total environmentally-related health
effects, exceeding the effects from other environmental
risk factors, such as environmental tobacco smoking
and lead contamination in drinking water (68). 
BIOLOGICAL MECHANISMS
The mechanisms by which air pollution influences the
risk of cardiovascular disease are still under
investigation. Most of the research in the past 15 years
has been focused on the effects of particulates despite
the evidence of associations for other pollutants,
especially for acute effects.   In any event, several
potential pathophysiological pathways for the effects of
particles have been suggested (18;69). First, repeated
inhalation of ambient particulates may result in low-to-
moderate-grade pulmonary oxidative stress and
inflammation (70-73), which subsequently triggers
systemic inflammatory responses with a cascade of
reactions: production and mobilization of
proinflammatory leukocytes and platelets into the
circulation (74;75); increase in circulating
inflammatory mediators, such as interleukins (IL)-6
(76;77); and stimulation of the production of acute
phase proteins, such as C-reactive protein and
fibrinogen (70). This induced systemic inflammatory
response may in turn lead to increasing blood
coagulability, accelerating atherosclerosis progression,
and ultimately precipitating or aggravating
cardiovascular events (78-80). This possible biological
mechanism, proposed by Seaton et al. (79) and van
Eeden et al. (80), has been supported by accumulated
epidemiological evidence (67;81) that exposure to
ambient fine particles is positively associated with
development of atherosclerosis. Second, it has been
hypothesized that sustained inflammation of the lung
may also exacerbate pre-existing lung diseases such as
chronic obstructive pulmonary disease, which further
contributes to cardiovascular risk (82). A third
hypothesized pathophysiological pathway suggests that
ultrafine particles and soluble components of fine
particles may cross the pulmonary epithelium into the
circulation, thus conferring a direct effect on the
cardiovascular system by altering cardiac autonomic
function: perhaps contributing to the instability of a
vascular plaque or initiate cardiac arrhythmias (18;69).
There is evidence that decreases in resting heart rate, an
Figure 3: Photographs of air pollution in Montreal and Beijing. Panel A: a “clean” day in Montreal, August 27, 2002, mean concentration of fine
particles 3 μg/m3. Panel B: a “dirty” day in Montreal, August 14, 2002, mean concentration of fine particles 37 μg/m3. Panel C: a “clean” day, in
Beijing, mean concentration of respirable particles 3 μg/m3; Panel D: a “dirty” day, in Beijing, mean concentration of respirable particles 254
μg/m3
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indicator of cardiac autonomic function, are associated
with increased risk of cardiovascular morbidity and
mortality in the elderly and those with  heart disease
(83;84). This latter pathway may explain both the acute
and the long-term cardiovascular effects of particulate
pollution. 
In contrast, it appears that the gaseous pollutants may
not play a great role in carcinogenesis because they are
not mutagenic. Although urban air also contains volatile
organic compounds (e.g., benzene) and polycyclic
aromatic hydrocarbons (e.g., benzo[a]pyrene) that are
both mutagenic and carcinogenic (21), most of these
compounds have not been investigated in population-
based epidemiological studies. The biological
mechanisms underlying the association between fine
particles and lung cancer have not been elucidated. It is
hypothesized that lung cancer develops through a series
of progressive pathological changes occurring in the
respiratory epithelium as a result of direct genotoxicity
effects of particulate air pollution (85;86). Some studies
have suggested that urban air pollution, in particular
polycyclic aromatic hydrocarbons, may cause cancer
mediated through the formation of DNA adducts (87-
90). Polycyclic aromatic hydrocarbons can adhere to
fine particles (91). Indeed, it was found that more than
90% of the particulate phase of polycyclic aromatic
hydrocarbons are associated physically with
particulates under 3.3 μm (92).
CONCLUSIONS
Air pollution does not recognize national boundaries
and it may be transported over distances of thousands
miles (20). Even at its current level, air pollution
threatens the health of entire populations. Air pollution
is a growing, global problem. Yet approaches to
controlling air pollution have not been up to the task.
The overall evidence from the past and present
epidemiological studies strongly supports tighter
standards for air pollution, especially particulate
pollutants, in Canada and in other countries.
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